A phase 3 clinical trial co-led by Mount Sinai researchers is the first to show that immunotherapy after surgery to remove bladder cancer can reduce the risk of relapse for patients who are at high risk of their cancer returning in a deadly metastatic form, according to results published in The New England Journal of Medicine. The immunotherapy nivolumab was used as an adjuvant therapy, which is given after surgery in the hopes of maximizing its effectiveness.
Vitamins and minerals are micronutrients required by the body to carry out a range of normal functions. However, these micronutrients are not produced in our
Macronutrients hog the spotlight. Everyone is talking about eating the right amount of proteins, fats, and carbohydrates for fitness goals, but there’s another type of
Commercial gyms are closed for at least the next couple of months due to the coronavirus outbreak. As a result, people are left scrambling to
Low testosterone is no joke. Did you know that testosterone levels in men have been on a steady decline since the 1980s? One study found
